Maria Sainz is Named Board Chair of Onera Health

Onera Health has recruited Maria Sainz to lead its Board of Directors. Sainz’s experience in the healthcare technology sector and her proven track record in strategic leadership will be instrumental as the company strives to increase access to cost-effective home polysomnography (PSG) through its Onera PSG-as-a-Service solution, executives said.

“We are excited to welcome Maria Sainz as our new chair of the board,” Onera Health Founder/CEO Ruben de Francisco stated. “Maria’s profound experience in both the U.S. and Europe will be invaluable in our company’s growth journey. Her guidance will help align our strategic vision with our commercial and operational goals. We believe her leadership will be crucial as we continue to enhance access to affordable, comprehensive sleep testing through our home polysomnography solution.”

Sainz has more than 30 years of medical device industry experience, having held leadership positions at several private and publicly traded organizations. Her background includes senior roles in strategic planning, operations management, and business development; in addition to her skill in executing complex business strategies, Sainz is well-known for her ability to successfully scale medtech organizations, and she’s played a key role in multiple exits. Most recently, Sainz was an independent board member of Shockwave Medical, which was acquired by Johnson & Johnson in a multi-billion-dollar transaction.

Sainz currently is the CEO of Hyperfine. She was previously the president and CEO of AEGEA Medical, Cardiokinetix, and Concentric Medical Inc. Additionally, she has been a board member of multiple healthtech companies, including Spectranetics Corp., Avanos Medical, Orthofix Medical Inc., Atrion Corp., and Shockwave Medical, along with several other private companies. Her expertise in groundbreaking health technology startups aligns well with Onera Health’s commitment to leveraging technology to address pressing healthcare challenges in the field of sleep medicine.

“I am honored to take on this role at Onera Health. Sleep is a vital component of overall health, affecting everything from cognitive function to emotional well-being,” Sainz commented. “Being able to bring the gold standard PSG testing to the home setting is highly innovative, and it will deliver high value to patients, clinicians, and providers. I look forward to collaborating with the team to deliver solutions that enhance the quality of care provided by sleep specialists to their patients. This initiative embodies a commitment to improving health outcomes for individuals across the globe.”

Onera Health is attempting to transform sleep medicine and remote monitoring. Its diagnostic solutions and services are poised to help millions of people struggling with sleep-related ailments while also impacting other medical fields by monitoring various chronic conditions, ultimately improving the health and quality of life of patients worldwide. The company’s solutions provide comprehensive sleep test data to physicians in various clinical and non-clinical environments to optimize patient care and reduce healthcare costs. Onera maintains offices in the Netherlands and the United States.